C. Van Dyke

Statistics

Publications

Citations

390

H-Index

Active since

1992

Affiliations

Cleveland Clinic(Current)

Multiple Sclerosis Center of Atlanta

C. Van Dyke is an author at Cleveland Clinic specializing in disability status determination, disability status analysis, and multiple sclerosis therapy.

Publications per year

1992–1996

Publications

Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

Donald E. Goodkin, Richard A. Rudick, Sharon V. Medendorp et al. · Annals of Neurology · 1995 · 305 citations

Pharmacy, Neurology, Pharmacotherapy +14

Low-dose oral methotrexate in chronic progressive multiple sclerosis

Donald E. Goodkin, R. A. Rudick, S. VanderBrug Medendorp et al. · Neurology · 1996 · 75 citations

Medicine, Neurology, Radiology +16

Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.

Donald E. Goodkin, R. A. Rudick, S. VanderBrug Medendorp et al. · PubMed · 1992 · 10 citations

Pharmacy, Pharmacotherapy, Disability Management +12

1–3 of 3